Announce Date | 02/25/2025 |
EPS Normalized Actual | $-0.79 (Miss by $-0.64) |
EPS GAAP Actual | $-0.79 (Miss by $-0.64) |
Revenue Actual | $1.83222B |
Revenue Surprise | Beat by $1832.22M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.09796 |
EPS GAAP Estimate | $1.09796 |
Revenue Estimate | $2.18365924B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 3.63 | 3.56 | 3.36689 | 3.81245 | 1 |
Dec 2027 | 3.08 | 4.19 | 2.83366 | 3.40309 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -1 | -1 | 1.83222B | -19.17% | 1832.22M |
FQ3 2024 (Sep 2024) | 0 | 0 | 2.14393B | -20.31% | 2143.93M |
FQ2 2024 (Jun 2024) | 0.33 | 0.33 | 2.01747B | 11.58% | 2017.47M |
FQ1 2024 (Mar 2024) | -0.0636 | -0.0636 | 1.98083B | 14.92% | 1980.83M |
FQ4 2023 (Dec 2023) | 4.74 | 4.74 | 2.18351B | 17.16% | 2183.51M |
FQ3 2023 (Sep 2023) | 2.85 | 2.85 | 2.57931B | 100% | 2579.31M |
FQ2 2023 (Jun 2023) | 0.5 | 0.5 | 1.78393B | -18.07% | 1783.93M |
FQ1 2023 (Mar 2023) | 3.96 | 3.96 | 1.68521B | 100% | 1685.21M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
1.09796
Consensus Revenue Estimates
2.18365924B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.04 | -- | 0.927 | 1.20705 | 1 |
FQ2 2027 (Jun 2027) | 1.32 | -- | 1.17657 | 1.53203 | 1 |
FQ1 2027 (Mar 2027) | -0.15 | -- | -0.17409 | -0.1337 | 1 |
FQ4 2026 (Oct 2026) | 1.27158 | -- | 1.17342 | 1.39763 | 1 |
FQ3 2026 (Jul 2026) | 1.27844 | -- | 1.17975 | 1.40517 | 1 |
FQ2 2026 (Jun 2026) | 0.67594 | -- | 0.62851 | 0.74584 | 1 |
FQ1 2026 (Mar 2026) | 0.65908 | -- | 0.61283 | 0.72724 | 1 |
FQ4 2025 (Oct 2025) | 1.41281 | 170.78 | 1.30374 | 1.55286 | 2 |
FQ3 2025 (Jul 2025) | 1.3796 | -- | 1.2731 | 1.51636 | 2 |
FQ2 2025 (Jun 2025) | 1.09796 | 69.94 | 1.02092 | 1.21151 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.68B | -- | 3.37B | 4.14B | 2 |
FQ2 2027 (Jun 2027) | 3.45B | -- | 3.17B | 3.88B | 2 |
FQ1 2027 (Mar 2027) | 3.24B | -- | 2.97B | 3.64B | 2 |
FQ4 2026 (Oct 2026) | 2.07B | -- | 1.95B | 2.23B | 1 |
FQ3 2026 (Jul 2026) | 2.05B | -- | 1.93B | 2.21B | 1 |
FQ2 2026 (Jun 2026) | 2.05B | -- | 1.94B | 2.21B | 1 |
FQ1 2026 (Mar 2026) | 2.03B | -- | 1.92B | 2.19B | 1 |
FQ4 2025 (Oct 2025) | 2.21B | 16.94 | 2.07B | 2.37B | 0 |
FQ3 2025 (Jul 2025) | 2.18B | 1.82 | 2.05B | 2.35B | 0 |
FQ2 2025 (Jun 2025) | 2.18B | 7.61 | 2.07B | 2.36B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -1 | -1 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 0.33 | 0.33 | 100% | |
FQ1 2024 (Mar 2024) | -0.0636 | -0.0636 | 100% | |
FQ4 2023 (Dec 2023) | 4.74 | 4.74 | 100% | |
FQ3 2023 (Sep 2023) | 2.85 | 2.85 | 100% | |
FQ2 2023 (Jun 2023) | 0.5 | 0.5 | 100% | |
FQ1 2023 (Mar 2023) | 3.96 | 3.96 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1.83B | $1832.22M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.14B | $2143.93M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.02B | $2017.47M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.98B | $1980.83M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.18B | $2183.51M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.58B | $2579.31M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.78B | $1783.93M | 100% |
FQ1 2023 (Mar 2023) | $0B | $1.69B | $1685.21M | 100% |